• NSC 87877: A Causal Map of Shp2 Signaling

  2026-08-27

  NSC 87877 is a potent Shp2 inhibitor for separating catalytic phosphatase activity from broader SHP2 pathway effects. This article translates stroke-neuroinflammation findings into a rigorous assay strategy spanning EGF signaling, microglia, leukemia, and inflammatory pain research.

• Machine Learning Discovery of Senolytics

  2026-08-27

  Smer-Barreto et al. used cost-effective machine learning trained exclusively on published data to prioritize senolytic candidates despite sparse and heterogeneous evidence. Computational screening followed by human-cell validation identified ginkgetin, periplocin, and oleandrin, illustrating how data-driven prioritization can reduce early drug-discovery costs without replacing experimental confirmation.

• Erlotinib (NSC 718781): EGFR Mechanism & Use

  2026-08-26

  Erlotinib, also called NSC 718781, is an orally bioavailable EGFR tyrosine kinase inhibitor that competitively occupies the intracellular ATP-binding site. Its reported biochemical and cellular potency supports EGFR pathway studies, while receptor-complex findings indicate that cellular context can modify EGFR-associated signaling outputs.

• Mifepristone (RU486) Applied Research Workflows

  2026-08-26

  Mifepristone (RU486) enables controlled progesterone receptor blockade across oncology, reproductive biology, and hormone-signaling assays. This practical guide connects dose design, pathway validation, tissue-specific controls, and troubleshooting to help researchers distinguish receptor-driven effects from formulation or exposure artifacts.

• Epidermal Growth Factor: Recombinant Human EGF Guide

  2026-08-25

  Epidermal Growth Factor (EGF), human recombinant, is an E. coli-expressed research protein for controlled EGFR stimulation. Product specifications support defined identity, purity, endotoxin, handling, and BALB/c 3T3 activity benchmarks, while peer-reviewed evidence shows that EGF can stimulate MAPK-dependent migration without necessarily inducing invasion.

• Dehydroepiandrosterone (DHEA) Research Workflows

  2026-08-25

  Dehydroepiandrosterone (DHEA) supports distinct experimental strategies, from modeling inflammatory ovarian dysfunction to testing neuroprotection and apoptosis inhibition. This workflow-focused guide shows how to separate disease induction from protective dosing, control steroid solubility, and connect granulosa-cell readouts with macrophage biology.

• Phosphatase Inhibitor Cocktail 1 for Chordoma Assays

  2026-08-24

  Learn how to use Phosphatase Inhibitor Cocktail 1 to preserve labile phosphorylation during chordoma lysis, immunoblotting, immunoprecipitation, and phosphoproteomic workflows. The guide translates an IDH1–redox metabolism study into practical assay controls while separating evidence-backed findings from recommended starting conditions.

• SP600125: A Practical JNK Inhibitor Workflow

  2026-08-24

  SP600125 is a reversible, ATP-competitive JNK inhibitor for dissecting c-Jun signaling in inflammation, apoptosis, and cancer research. This workflow connects biochemical selectivity with cellular dose selection, pathway controls, and a hypothesis-driven extension of recent orofacial pain research.

• Methylprednisolone as a Translational Stress Test

  2026-08-23

  Methylprednisolone is more than an anti-inflammatory reference compound: as a synthetic glucocorticoid receptor agonist, it can connect immune signaling, tissue injury, and skeletal remodeling in translational models. This article examines how to use Methylprednisolone strategically in mechanistic assays and glucocorticoid-induced osteonecrosis research while maintaining rigorous controls, realistic claims, and clinically relevant endpoints.

• Norovirus Co-opts NINJ1 for Selective Secretion

  2026-08-22

  Song et al. show that murine norovirus repurposes the membrane-rupture effector NINJ1 to release the viral NS1 protein after caspase-3 processing. The study combines CRISPR screening, cell biology, mutagenesis, and mouse infection experiments to define an unconventional secretion pathway that links viral immune evasion with regulated cell death.

• Lapatinib Beyond HER2: A Translational Research Playbook

  2026-08-22

  Lapatinib, also known as GW572016, is more than a biochemical EGFR and HER2 inhibitor. This thought-leadership guide examines how its reversible kinase mechanism can support receptor-defined studies, phenotype-first investigations in aggressive breast cancer models, and translational assay design while keeping potency, target engagement, and therapeutic relevance conceptually separate.

• Thioredoxin Control of CHK1 Inhibitor Sensitivity

  2026-08-21

  The reference study identifies thioredoxin 1 as a determinant of checkpoint kinase 1 inhibitor sensitivity in non-small cell lung cancer and connects this response to redox recycling of ribonucleotide reductase subunit RRM1. Its findings support a mechanistically focused combination strategy in which thioredoxin reductase inhibition disrupts deoxynucleotide production and intensifies replication stress caused by CHK1 blockade.

• Cycloheximide: A Translational Lens on Protein Turnover

  2026-08-20

  Cycloheximide is more than a routine translation blocker: it is a temporal probe for testing whether protein synthesis sustains apoptosis, ferroptosis resistance, and disease-associated phenotypes. This article connects its ribosomal mechanism to the GPX4-driven platinum resistance described in lung cancer brain metastasis and offers a disciplined framework for translational validation.

• Cytoskeleton-Dependent Autophagy Under Compression

  2026-08-20

  The reference study provides direct evidence that compression-induced autophagy depends primarily on cytoskeletal microfilaments, while microtubules make a supporting contribution. Its combination of controlled mechanical loading, cytoskeletal polymerization perturbation, fluorescence imaging, and western blotting offers a useful framework for dissecting mechanotransduction without treating autophagy as a purely chemical stress response.

• Recombinant Human EGF: Reliable Cell Assays

  2026-08-19

  Learn how Epidermal Growth Factor (EGF), human recombinant (SKU P1008) can improve interpretation of proliferation, viability, migration, and cytotoxicity workflows. This scenario-based guide connects product specifications with published A549 migration findings and practical protein-handling decisions.

7843 records 1/523 page Next 12345 下5页 Last page